Clinical trial NCT04272723: Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians
Official title: Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Survey
Venous Thromboembolism
Deep Vein Thrombosis
Pulmonary Embolism
Anticoagulant
Keywords: Survey
Venous Thromboembolism
Deep Vein Thrombosis
Pulmonary Embolism
Anticoagulant
Clinical Practice
Therapeutic management
Lead sponsor: Centre Hospitalier Universitaire, Amiens
Sponsor class: OTHER
First posted: 2020-02-17
Enrollment: 383
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: OTHER
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Vascular medicine physicians (VMP) practicing in the hospital and in the community settings.

Participating VMP will prospectively collect data on the management of incident venous thromboembolic (VTE) disease cases.

After that, vascular medicine physicians will answer a phone questionnaire on their general VTE management

Brief summary: In France, venous thromboembolic (VTE) disease is usually managed by vascular medicine physicians (VMP). The national OPTIMEV study, conducted more than 12 years ago among VMP practicing in hospital and in the community described the management of VTE in routine clinical practice. Since then a large number of practice changing studies have been published. This includes trials that have validated the use of direct oral anticoagulants (DOAC), the new standard of care of VTE, as per new national and international guidelines. Management of VTE in 2019 appears to be significantly different from the one that prevailed more than 10 years ago when the last national survey was conducted. It is therefore important to have an update on the routine clinical practice management of VTE by VMP. In this perspective the investigators aim to conduct a national survey among VMP practicing in France


Eligibility criteria: Inclusion Criteria:

* vascular medicine physicians who are active members of the SFMV (French Society of Vascular Medicine)
* vascular medicine physicians registered as willing to do medical research

Exclusion Criteria:

* vascular medicine physicians who refuse to provide consent
* vascular medicine physicians who are retired
* non-practicing vascular medicine physicians

Primary outcomes:
measure: Inter-practician variability of clinical care of venous thromboembolic in routine clinical practice
timeFrame: up to 3 months after inclusion
Secondary outcomes:
measure: Inter-practician variability of clinical care of venous thromboembolic according to patient age
timeFrame: up to 6 months after inclusion
measure: Inter-practician variability of clinical care of venous thromboembolic according to patient body weight
timeFrame: up to 6 months after inclusion
measure: Inter-practician variability of clinical care of venous thromboembolic according to patient bleeding risk
timeFrame: up to 6 months after inclusion
Other outcomes:
Locations:
city: Amiens
country: France
facility: CHU Amiens
Study officials:
affiliation: CHU Amiens
name: Simon Soudet, MD
role: PRINCIPAL_INVESTIGATOR
References: